Parmar Kush
SEC-identified person · CIK 1664281 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Entrada Therapeutics, Inc. TRDA | Director | filed 2021–2026 |
| Camp4 Therapeutics Corp CAMP | Officer | filed 2024–2025 |
| Skye Bioscience, Inc. SKYE | Officer | filed 2023–2025 |
| Artiva Biotherapeutics, Inc. ARTV | Officer | filed 2024–2024 |
| Rallybio Corp RLYB | Director | filed 2021–2024 |
| Imara Inc. IMRA | Officer | filed 2023–2024 |
| Cincor Pharma, Inc. CINC | Officer | filed 2022–2023 |
| Akouos, Inc. AKUS | Director | filed 2020–2022 |
| Q32 Bio Inc. QTTB | Director | filed 2018–2022 |
| Vor Biopharma Inc. VOR | Director | filed 2021–2022 |
| Cabaletta Bio, Inc. CABA | Officer | filed 2019–2021 |
| IPI Legacy Liquidation Co IMPLQ | Officer | filed 2021–2021 |
| 5:01 Acquisition Corp. FVAM | Director · Co-CEO | filed 2020–2020 |
| Aprea Therapeutics, Inc. APRE | Officer | filed 2019–2020 |
| Arvinas, INC. AVRN | Director | filed 2018–2019 |
| Scpharmaceuticals Inc. SCPH | Director | filed 2017–2018 |
| Audentes Therapeutics, Inc. BOLD | Director | filed 2016–2018 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.